MXPA03011790A - Agente para la procteccion de neuronas de la retina. - Google Patents

Agente para la procteccion de neuronas de la retina.

Info

Publication number
MXPA03011790A
MXPA03011790A MXPA03011790A MXPA03011790A MXPA03011790A MX PA03011790 A MXPA03011790 A MX PA03011790A MX PA03011790 A MXPA03011790 A MX PA03011790A MX PA03011790 A MXPA03011790 A MX PA03011790A MX PA03011790 A MXPA03011790 A MX PA03011790A
Authority
MX
Mexico
Prior art keywords
protection
agent
retinal neurons
retinal
neurons
Prior art date
Application number
MXPA03011790A
Other languages
English (en)
Inventor
Ishigaki Kaoru
Original Assignee
Ortho Mcnell Pharmaceuticals I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcnell Pharmaceuticals I filed Critical Ortho Mcnell Pharmaceuticals I
Publication of MXPA03011790A publication Critical patent/MXPA03011790A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Esta invencion describe un agente para la proteccion de neuronas de la retina que comprende, como un ingrediente efectivo, el derivado de sulfamato que tiene la siguiente formula: (ver formula) y un metodo para la proteccion de neuronas de la retina a traves del uso de dicho derivado de sulfamato.
MXPA03011790A 2001-06-18 2002-06-14 Agente para la procteccion de neuronas de la retina. MXPA03011790A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001183192A JP2004331502A (ja) 2001-06-18 2001-06-18 視神経細胞保護剤
PCT/JP2002/005935 WO2002102369A2 (en) 2001-06-18 2002-06-14 Agent for protection of retinal neurons

Publications (1)

Publication Number Publication Date
MXPA03011790A true MXPA03011790A (es) 2004-04-02

Family

ID=19023172

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03011790A MXPA03011790A (es) 2001-06-18 2002-06-14 Agente para la procteccion de neuronas de la retina.

Country Status (9)

Country Link
US (1) US7153837B2 (es)
EP (1) EP1414437A2 (es)
JP (1) JP2004331502A (es)
AR (1) AR034508A1 (es)
AU (1) AU2002309280B2 (es)
CA (1) CA2451475A1 (es)
MX (1) MXPA03011790A (es)
NZ (1) NZ529955A (es)
WO (1) WO2002102369A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1783205B1 (en) * 2004-06-18 2024-02-21 Riken Method of inducing the differentiation of embryonic stem cells into nerve by serum-free suspension culture
EP2119440A1 (en) * 2005-05-17 2009-11-18 Santen Pharmaceutical Co., Ltd. Amidino derivatives for use in the prevention or treatment of retinitis pigmentosa and Leber's disease
RU2007148444A (ru) * 2005-05-25 2009-06-27 Янссен Фармацевтика Н.В. (Be) Педиатрическая композиция топирамата
US20090076128A1 (en) * 2007-09-15 2009-03-19 Protia Llc Deuterium-enriched topiramate
US20210169844A1 (en) 2019-12-10 2021-06-10 Tulex Pharmaceuticals Inc. Compositions and methods for treating epilepsy, seizures and other conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
WO1998000124A1 (en) * 1996-06-28 1998-01-08 Ortho Pharmaceutical Corporation Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration
JP2003521471A (ja) * 1999-04-08 2003-07-15 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 慢性神経変性疾患を処置することに有用な抗痙攣薬誘導体

Also Published As

Publication number Publication date
US20040171558A1 (en) 2004-09-02
EP1414437A2 (en) 2004-05-06
JP2004331502A (ja) 2004-11-25
AU2002309280B2 (en) 2007-01-25
US7153837B2 (en) 2006-12-26
WO2002102369A2 (en) 2002-12-27
AR034508A1 (es) 2004-02-25
WO2002102369A3 (en) 2003-07-24
NZ529955A (en) 2007-01-26
CA2451475A1 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
WO2003057698A3 (en) Spiroazacyclic compounds as monoamine receptor modulators
IL157254A0 (en) N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
WO2005079756A3 (en) Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
WO2006113552A3 (en) Cyanoarylamines
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
WO2005046603A3 (en) Pyridine compounds
HK1094425A1 (en) Substituted 2-aminotetralines for the preventive treatment of parkinson's disease
WO2005030753A3 (en) Therapeutic agents useful for treating pain
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
WO2003057145A3 (en) SUBSTITUTED 4,9-DIHYDROCYCLOPENTA[imn]PHENANTHRIDINE-5-ONES DERIVATIVES THEREOF AND THEIR USES
BR0213464A (pt) Derivados de 3-azabiciclo[3.1.0]hexano como antagonistas receptores de opióide
HK1076816A1 (es)
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MXPA05013151A (es) 3-fluoro-piperidinas como antagonistas de n-metil-d-aspartato/nr2b.
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
MXPA03011790A (es) Agente para la procteccion de neuronas de la retina.
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
TW200514553A (en) Therapeutic agent for hepatitis C
WO2007065093A3 (en) Pyrrolidineanilines
AU2003291143A1 (en) Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance
WO2003028652A3 (en) Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
MY136965A (en) 1,4-disubstituted piperidine compounds, their preparation and use as medicaments
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
WO2004058141A3 (en) An agent for controlling bcl-2 expression comprising ginsenoside f1 as an active component